Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Empiric antifungal and outcome in ICU patients.

Trifi A, Abdellatif S, Daly F, Nasri R, Touil Y, Ben Lakhal S.

Tunis Med. 2019 Apr;97(4):579-587.

2.

Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.

Trifi A, Abdellatif S, Abdennebi C, Daly F, Nasri R, Touil Y, Ben Lakhal S.

Ann Clin Microbiol Antimicrob. 2018 Nov 16;17(1):39. doi: 10.1186/s12941-018-0292-7.

3.

Ultrasound stroke volume variation induced by passive leg raising and fluid responsiveness: An observational cohort study.

Trifi A, Abdellatif S, Daly F, Nasri R, Touil Y, Ben Lakhal S.

Med Intensiva. 2019 Jan - Feb;43(1):10-17. doi: 10.1016/j.medin.2017.11.002. Epub 2017 Dec 16. English, Spanish.

4.

Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells.

Touil Y, Segard P, Ostyn P, Begard S, Aspord C, El Machhour R, Masselot B, Vandomme J, Flamenco P, Idziorek T, Figeac M, Formstecher P, Quesnel B, Polakowska R.

Sci Rep. 2016 Jul 28;6:30405. doi: 10.1038/srep30405.

5.

Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment.

Tomellini E, Touil Y, Lagadec C, Julien S, Ostyn P, Ziental-Gelus N, Meignan S, Lengrand J, Adriaenssens E, Polakowska R, Le Bourhis X.

Stem Cells. 2015 Feb;33(2):342-53. doi: 10.1002/stem.1849.

6.

Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.

Ostyn P, El Machhour R, Begard S, Kotecki N, Vandomme J, Flamenco P, Segard P, Masselot B, Formstecher P, Touil Y, Polakowska R.

Cell Commun Signal. 2014 Sep 17;12:52. doi: 10.1186/s12964-014-0052-z.

7.

Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.

Touil Y, Igoudjil W, Corvaisier M, Dessein AF, Vandomme J, Monté D, Stechly L, Skrypek N, Langlois C, Grard G, Millet G, Leteurtre E, Dumont P, Truant S, Pruvot FR, Hebbar M, Fan F, Ellis LM, Formstecher P, Van Seuningen I, Gespach C, Polakowska R, Huet G.

Clin Cancer Res. 2014 Feb 15;20(4):837-46. doi: 10.1158/1078-0432.CCR-13-1854. Epub 2013 Dec 9.

8.

Insulin-like growth factor 1 receptor and p38 mitogen-activated protein kinase signals inversely regulate signal transducer and activator of transcription 3 activity to control human dental pulp stem cell quiescence, propagation, and differentiation.

Vandomme J, Touil Y, Ostyn P, Olejnik C, Flamenco P, El Machhour R, Segard P, Masselot B, Bailliez Y, Formstecher P, Polakowska R.

Stem Cells Dev. 2014 Apr 15;23(8):839-51. doi: 10.1089/scd.2013.0400. Epub 2014 Jan 17.

9.

Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.

Seguin J, Brullé L, Boyer R, Lu YM, Ramos Romano M, Touil YS, Scherman D, Bessodes M, Mignet N, Chabot GG.

Int J Pharm. 2013 Feb 28;444(1-2):146-54. doi: 10.1016/j.ijpharm.2013.01.050. Epub 2013 Feb 1.

PMID:
23380621
10.

The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.

Touil Y, Zuliani T, Wolowczuk I, Kuranda K, Prochazkova J, Andrieux J, Le Roy H, Mortier L, Vandomme J, Jouy N, Masselot B, Ségard P, Quesnel B, Formstecher P, Polakowska R.

Stem Cells. 2013 Apr;31(4):641-51. doi: 10.1002/stem.1333.

11.

Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.

Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, Jonneaux A, Ballot C, Balayssac S, Valable S, Corroyer-Dulmont A, Bernaudin M, Malet-Martino M, de Lassalle EM, Maboudou P, Formstecher P, Polakowska R, Mortier L, Marchetti P.

Cancer Res. 2012 Oct 1;72(19):5035-47. doi: 10.1158/0008-5472.CAN-12-0979. Epub 2012 Aug 3.

12.

Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.

Touil YS, Auzeil N, Boulinguez F, Saighi H, Regazzetti A, Scherman D, Chabot GG.

Biochem Pharmacol. 2011 Dec 1;82(11):1731-9. doi: 10.1016/j.bcp.2011.07.097. Epub 2011 Aug 4.

13.

Development of a liposomal formulation of the natural flavonoid fisetin.

Mignet N, Seguin J, Ramos Romano M, Brullé L, Touil YS, Scherman D, Bessodes M, Chabot GG.

Int J Pharm. 2012 Feb 14;423(1):69-76. doi: 10.1016/j.ijpharm.2011.04.066. Epub 2011 May 6.

PMID:
21571054
14.

Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.

Touil YS, Seguin J, Scherman D, Chabot GG.

Cancer Chemother Pharmacol. 2011 Aug;68(2):445-55. doi: 10.1007/s00280-010-1505-8. Epub 2010 Nov 11.

15.

Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization.

Touil YS, Fellous A, Scherman D, Chabot GG.

Nutr Cancer. 2009;61(3):310-21. doi: 10.1080/01635580802521346.

16.

Clinical study of 40 cases of incontinentia pigmenti.

Hadj-Rabia S, Froidevaux D, Bodak N, Hamel-Teillac D, Smahi A, Touil Y, Fraitag S, de Prost Y, Bodemer C.

Arch Dermatol. 2003 Sep;139(9):1163-70.

PMID:
12975158
17.

[Infiltration of the nostril].

Touil Y, Belaich S, Lachenaud M, Sigal-Grinberg M.

Ann Dermatol Venereol. 2002 Dec;129(12):1397-8. French. No abstract available.

PMID:
12536181
18.

[The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital].

Lachgar T, Touil Y.

Allerg Immunol (Paris). 2001 Apr;33(4):173-5. French.

PMID:
11434197

Supplemental Content

Support Center